JESSIE HASH: Open Payments
NPI 1104416643 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$741 in 28 payments from 8 companies in 2025. Trend: 2023 $361 · 2024 $612 · 2025 $741
Food & beverage: $741
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $264 |
| AstraZeneca Pharmaceuticals LP | 10 | $209 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $60 |
| PFIZER INC. | 3 | $49 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: CARDIOMEMS, ULTREON, LEQVIO, WAINUA, JARDIANCE, FARXIGA, ELIQUIS, LOKELMA.
Industry payments across TX — which companies pay providers there.
